论文部分内容阅读
目的:分析α-干扰素栓联合微波治疗宫颈糜烂疗与安全性。方法:2014年2月~2016年3月,妇科门诊收治的宫颈糜烂病变114例,随机数字表达法分组,对照组、观察组各入选57例,均采用微波治疗,观察组联合α-干扰素治疗。结果:两组均未见不良反应。观察组治愈率、愈显率高于对照组,差异有统计学意义(P<0.05);治疗后,组内对比观察组与对照组白带清洁度低于治疗前,组间对比观察组低于对照组,差异有统计学意义(P<0.05)。6个月后,观察组复发率1.8%(1/57),低于对照组19.3%(11/57),差异有统计学意义(P<0.05)。结论:α-干扰素栓联合微波治疗宫颈糜烂有助于增进疗效,降低复发风险。
Objective: To analyze the treatment and safety of cervical erosion treated with α-interferon suppository and microwave. Methods: From February 2014 to March 2016, 114 patients with cervical erosion treated by gynecology clinic were divided into two groups according to random number expression method. The control group and observation group were all selected by microwave. The observation group was treated with α-interferon treatment. Results: No adverse reaction was found in both groups. The cure rate and the cure rate of the observation group were higher than those of the control group (P <0.05). After treatment, the cleanliness of the leucorrhea in the observation group and the control group was lower than that before treatment, and the control group was lower than the control group Control group, the difference was statistically significant (P <0.05). After 6 months, the recurrence rate was 1.8% (1/57) in the observation group and 19.3% (11/57) in the control group, with a significant difference (P <0.05). Conclusion: Interferon-alpha suppository combined with microwave treatment of cervical erosion can help to improve curative effect and reduce the risk of recurrence.